Bienaime Jean Jacques

Immunome, Inc. · Director

Bienaime Jean Jacques is listed in public filings as director. This Bienaime Jean Jacques insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Immunome, Inc. (IMNM), Keros Therapeutics, Inc. (KROS), Incyte Corp (INCY), and Ascendis Pharma A/S (ASND). Investors use Bienaime Jean Jacques's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Immunome, Inc.IMNM$194k10k sharesSellJun 5, 2026$19.41$22.11
Immunome, Inc.IMNM$117k6k sharesBuyJun 5, 2026$19.48$22.11
Immunome, Inc.IMNM$68k3.5k sharesBuyJun 5, 2026$19.46$22.11
Immunome, Inc.IMNM$19k1k sharesBuyJun 5, 2026$19.27$22.11
Immunome, Inc.IMNM$9.7k500 sharesSellJun 5, 2026$19.44$22.11